Skip to main content
placeholder image

O-103 A comparison of the antitumour efficacy of ZD6474 and gefitinib(Iressa¿) in patients with NSCLC: Results of a randomized, double-blind Phase II study

Journal Article


Abstract


Publication Date


  • 2005

Citation


  • Natale, R., Bodkin, D., Govindan, R., Sleckman, B., Rizvi, N., Capo, A., . . . Ranson, M. (2005). O-103 A comparison of the antitumour efficacy of ZD6474 and gefitinib(Iressa¿) in patients with NSCLC: Results of a randomized, double-blind Phase II study. Lung Cancer, 49, s37. doi:10.1016/s0169-5002(05)80237-5

Web Of Science Accession Number


Start Page


  • s37

Volume


  • 49

Abstract


Publication Date


  • 2005

Citation


  • Natale, R., Bodkin, D., Govindan, R., Sleckman, B., Rizvi, N., Capo, A., . . . Ranson, M. (2005). O-103 A comparison of the antitumour efficacy of ZD6474 and gefitinib(Iressa¿) in patients with NSCLC: Results of a randomized, double-blind Phase II study. Lung Cancer, 49, s37. doi:10.1016/s0169-5002(05)80237-5

Web Of Science Accession Number


Start Page


  • s37

Volume


  • 49